Skip to content

Clinical trials

Phase 1/2 Carcinoma, Non-Small-Cell Lung trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Phase: Phase 1/2 Country / region: China Clear all

145 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20121
20131
20142
20154
20169
20179
20187
20194
20209
202115
202218
202318
202414
202519
202613

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting58
Unknown status38
Completed18
Active, not recruiting18
Terminated7
Not yet recruiting5
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca5
Shanghai Chest Hospital5
Betta Pharmaceuticals Co., Ltd.4
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.4
Sun Yat-sen University4
Allist Pharmaceuticals, Inc.3
BioNTech SE3
Dizal Pharmaceuticals3
DualityBio Inc.3
Novartis Pharmaceuticals3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung145
Lung Neoplasms17
Colorectal Neoplasms14
Stomach Neoplasms11
Squamous Cell Carcinoma of Head and Neck10
Carcinoma, Hepatocellular9
Neoplasms9
Breast Neoplasms8
Endometrial Neoplasms8
Melanoma8

Trials

Showing 1 to 25 of 145. Each trial links to its page on Pharma Observatory.

45 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.